CTU A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination with Background Therapy in Adult Participants with Pulmonary Arterial Hypertension

  • Brown, Martin (Primary Chief Investigator)
  • Morrisroe, Emma (Clinical Trial Unit Staff)
  • Chester, Catherine (Clinical Trial Unit Staff)
  • Contacos, Christine (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleKER-012-A201
AcronymKER-012-A201
StatusActive
Effective start/end date20/06/23 → 20/10/26